Reverse signalling of membrane TNF in human natural killer cells: a comparison of the effect of certolizumab pegol and other anti-TNF agents

Lignende værker

• Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
  af: Fossati, G, et al.
  Udgivet: (2010)
• Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
  af: Nesbitt A, et al.
  Udgivet: (2010-11-01)
• Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
  af: Henry, Alistair I, et al.
  Udgivet: (2011)
• Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling
  af: Boyer, Jean Frédéric, et al.
  Udgivet: (2016)
• The effects of anti–TNF agents on the expansion of T helper-type 17 cells driven by lipopolysaccharide-stimulated monocytes
  af: Fossati, Gianluca, et al.
  Udgivet: (2012)